Transpact Enterprises Ltd
Fixed Price IPO · BSE
- Price band
- ₹130 - ₹130
- Lot size
- 1,000 shares
- Issue amount
- ₹1.35 cr
- Total subscription
- 0×
- Opens
- 26 Aug 2019
- Closes
- 28 Aug 2019
- Allotment
- 3 Sept 2019
- Listing
- 5 Sept 2019
Offer at a glance
Issue overview
- Issue size
- 1,04,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,30,000
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,30,000
- Issue type
- Fixed Price IPO
- Shares before issue
- 2,82,730
- Shares after issue
- 3,86,730
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,000 | ₹1,30,000 |
| HNI | 2 | 2,000 | ₹2,60,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 2013, Maharashtra-based Transpact Enterprises Limited is a biotechnology startup focused on developing innovative and affordable solutions for specially-abled individuals. The company primarily designs, develops, and distributes the Vestibulator, a therapeutic device created to address vestibular dysfunctions. The Vestibulator is a co-patented technology of Transpact Enterprises and IRCC-IIT Bombay, and the company holds a license from the Society for Innovation and Entrepreneurship, IIT Bombay, to commercialize the product. While the design and customization of the device are handled in-house with the help of advanced software, the manufacturing process is outsourced to third-party vendors. Transpact Enterprises is dedicated to continuous innovation to enhance its offerings and improve the quality of life for its users.
Strengths
- Easy-to-use device with unique features
- Strong technical base for custom-made devices
- Quality assured and certified products
Promoters
Mr. Aslam Khan,
Mr. Anis Choudhery
Registrar & documents
Lead manager
Aryaman Financial Services Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
204 2nd Floor, Timmy Arcade, Makwana Road Marol, Andheri East, Mumbai-400 059
+91 9224763158
[email protected]Company website ↗Frequently Asked Questions
What is Transpact Enterprises IPO GMP today?
Currently, Transpact Enterprises IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹130. Track daily updates on IPO Premiums as bidding numbers unfold.
What is the lot size and minimum investment for Transpact Enterprises IPO?
The minimum bid lot size for Transpact Enterprises IPO is 1,000 shares. At the cut-off price of ₹130 per share, retail investors need a minimum application amount of ₹1,30,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Transpact Enterprises IPO allotment status be announced?
The allotment status for Transpact Enterprises IPO is scheduled to be finalized on 3 Sept 2019. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Transpact Enterprises IPO allotment status online by PAN?
To check Transpact Enterprises IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Transpact Enterprises Ltd' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.